HomeATXS • NASDAQ
add
Astria Therapeutics Inc
Previous close
$9.34
Day range
$9.31 - $9.75
Year range
$4.44 - $16.90
Market cap
544.50M USD
Avg Volume
231.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.01M | 43.38% |
Net income | -24.53M | -38.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 344.28M | 82.35% |
Total assets | 361.64M | 86.55% |
Total liabilities | 19.98M | 113.01% |
Total equity | 341.65M | — |
Shares outstanding | 56.43M | — |
Price to book | 2.14 | — |
Return on assets | -19.88% | — |
Return on capital | -20.72% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.53M | -38.40% |
Cash from operations | -27.96M | -96.14% |
Cash from investing | 6.19M | 154,800.00% |
Cash from financing | 15.30M | 13,810.00% |
Net change in cash | -6.48M | 54.24% |
Free cash flow | -23.32M | -112.62% |
About
Founded
2008
Headquarters
Website
Employees
59
